Literature DB >> 15325034

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.

Stamos Theocharis1, Alexandra Margeli, Philippe Vielh, Gregory Kouraklis.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for compounds which induce peroxisomal proliferation. PPAR-gamma, the best characterized of the PPARs, is a ligand-activated transcription factor and a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. Recent in vitro and in vivo studies suggest the importance of specific PPAR-gamma ligands as cell-cycle modulators, establishing their antineoplastic properties. In this review, the latest knowledge on the role of PPAR-gamma ligands as cell-cycle modulators is presented, discussing also their role in cell proliferation, apoptosis and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325034     DOI: 10.1016/j.ctrv.2004.04.004

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  38 in total

1.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

2.  Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.

Authors:  Costantinos Giaginis; Ekaterini Politi; Paraskevi Alexandrou; John Sfiniadakis; Gregory Kouraklis; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

3.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 4.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

5.  Peroxisome proliferator-activated receptor γ and colorectal cancer.

Authors:  Yun Dai; Wei-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

6.  Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

Authors:  R C Smallridge; J A Copland; M S Brose; J T Wadsworth; Y Houvras; M E Menefee; K C Bible; M H Shah; A W Gramza; J P Klopper; L A Marlow; M G Heckman; R Von Roemeling
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

7.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

8.  Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.

Authors:  Xishan Xiong; Yangliang Ye; Lili Fu; Bing Dai; Jieqiong Liu; Jieshuang Jia; Jing Tang; Lin Li; Li Wang; Jianhua Shen; Changlin Mei
Journal:  Invest New Drugs       Date:  2008-08-13       Impact factor: 3.850

Review 9.  Heme oxygenase and carbon monoxide initiate homeostatic signaling.

Authors:  Martin Bilban; Arvand Haschemi; Barbara Wegiel; Beek Y Chin; Oswald Wagner; Leo E Otterbein
Journal:  J Mol Med (Berl)       Date:  2007-11-22       Impact factor: 4.599

10.  Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.

Authors:  Stamatios Theocharis; Costas Giaginis; Aikaterini Parasi; Alexandra Margeli; John Kakisis; Emmanuel Agapitos; Gregorios Kouraklis
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.